Table 1 Baseline characteristics at initiation of rGH Therapy
Variable | Total N = 60 | GHD n = 23 | ISS n = 12 | SGA n = 9 | TS and variants n = 7 | Others n = 9 | P value |
|---|---|---|---|---|---|---|---|
Female, n (%) | 29 (48.3 %) | 9 (39.1 %) | 6 (50.0 %) | 4 (44.4 %) | 7 (100.0 %) | 3 (33.3 %) | 0.917* |
Nationality, Kuwaitis n (%) | 44 (73.3 %) | 16 (69.6 %) | 7 (58.3 %) | 8 (88.9 %) | 4 (57.1 %) | 9 (100.0 %) | 0.122 |
Age years, median (IQR)♦ | 9.0 (6.2, 10.7) | 6.4 (5.5, 10.7) | 10.6 (8.1, 10.9) | 7.8 (7.2, 9.7) | 9.9 (5.9, 10.7) | 8.4 (5.0, 12.4) | 0.407 |
Pre-pubertal, n/N (%) | 50/59 (83.3 %) | 21/23 (91.3 %) | 10/12 (83.3 %) | 9/9 (100.0 %) | 5/7 (71.4 %) | 5/8 (62.5 %) | 0.127 |
Height SDS, mean (SD)♣ | −2.77 (0.55) | −2.76 (0.50) | −2.84 (0.52) | −2.49 (0.54) | −2.82 (0.69) | −3.03 (0.69) | 0.432 |
BMI SDS, median (IQR)♠ | −0.46 (−1.25, 0.10) | −0.32 (−1.25, 0.27) | −0.44 (−1.91, −0.04) | −0.94 (−2.48, −.58) | 0.10 (−0.31, 0.65) | −0.27 (−0.71, 0.24) | 0.176 |